Rituximab in fibrillary glomerulonephritis: fumble or forward progress?

Nephrol Dial Transplant. 2021 Jan 1;36(1):11-13. doi: 10.1093/ndt/gfaa186.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Glomerulonephritis* / drug therapy
  • Humans
  • Pilot Projects
  • Rituximab / therapeutic use

Substances

  • Rituximab